国产精品99一区二区三_免费中文日韩_国产在线精品一区二区_日本成人手机在线

Triple pill treatment may effectively lower blood pressure: study

Source: Xinhua| 2018-08-15 00:25:17|Editor: yan
Video PlayerClose

WASHINGTON, Aug. 14 (Xinhua) -- A new low dose three-in-one pill to treat hypertension could transform the way high blood pressure is treated around the world, according to a study published on Tuesday in JAMA, a journal of the American Medical Association.

A trial led by the George Institute for Global Health revealed that 70 percent of patients reached blood pressure targets with the 'Triple Pill,' compared to just over half receiving normal care.

"It's estimated more than a billion people globally suffer from high blood pressure with the vast majority having poorly controlled blood pressure. Our results could help millions of people globally reduce their blood pressure and reduce their risk of heart attack or stroke," said Ruth Webster with the George Institute for Global Health.

The Triple Pill, consisted of the blood pressure medications telmisartan (20 mg), amlodipine (2.5 mg), and chlorthalidone (12.5 mg).

The researchers tested an entirely new way in Sri Lanka of treating hypertension by giving patients those three drugs, each at half dose, in a single pill for early treatment of high blood pressure.

Traditionally patients begin treatment with one drug at a very low dose, which is increased over time with additional drugs added and increased in dosage to try to reach target.

"This is not only time inefficient, it's costly. We also know that many doctors and patients find it too complicated and often don't stick to the process. This new approach is much simpler and it works," said Webster.

The trial enrolled 700 patients with an average age of 56 and blood pressure of 154/90 mm Hg. They were randomly assigned to receive either the combination pill or usual care.

Compared with patients receiving usual care, a significantly higher proportion of patients receiving the Triple Pill achieved their target blood pressure of 140/90 or less (with lower targets of 130/80 for patients with diabetes or chronic kidney disease).

The researchers are now looking at strategies to maximize uptake of the study results, including examining the acceptability of the Triple Pill approach to patients and their doctors, as well as cost-effectiveness which will be important for governments and other payers to consider.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011105521373903211
主站蜘蛛池模板: 衡阳县| 庆安县| 登封市| 衡山县| 兴仁县| 卫辉市| 赫章县| 大港区| 贞丰县| 江津市| 上饶市| 万载县| 新丰县| 芷江| 托里县| 衡东县| 化州市| 沙坪坝区| 温宿县| 双牌县| 新平| 全椒县| 台山市| 岱山县| 邵东县| 福安市| 宾阳县| 张家港市| 常宁市| 陵川县| 陈巴尔虎旗| 杭锦旗| 济南市| 抚远县| 乌恰县| 深圳市| 东光县| 武威市| 云阳县| 阿克苏市| 肇源县|